Opas expands access to HIV-preventing injection for Brazil and 13 countries

The Pan American Health Organization (Opas) is expanding access to lenacapavir, a twice-yearly injectable HIV prevention drug with nearly 100% efficacy in trials, to Brazil and 13 other countries. This marks a significant step in HIV prevention in the region, though rollout logistics and cost remain uncertain. The move could reduce HIV incidence and ease public health burdens.